News + Filings Transactions
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
|
Becker Daniel J.
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
05/11/2023 |
4
| Becker Daniel J. (Director) has filed a Form 4 on ACELYRIN, Inc.
Txns:
| Bought 3,000 shares
@ $18, valued at
$54k
Disposed of 23,243 options to buy
@ $18, valued at
$418.4k
Acquired 23,243 options to buy
@ $18, valued at
$418.4k
|
|
05/04/2023 |
4
| Becker Daniel J. (Director) has filed a Form 4 on ACELYRIN, Inc.
Txns:
| Granted 23,243 options to buy
@ $18, valued at
$418.4k
|
|
05/04/2023 |
3
| Becker Daniel J. (Director) has filed a Form 3 on ACELYRIN, Inc. |
06/23/2022 |
4
| Becker Daniel J. (Director) has filed a Form 4 on Day One Biopharmaceuticals, Inc.
Txns:
| Granted 28,700 options to buy
@ $16.29, valued at
$467.5k
|
|
06/01/2021 |
4
| Becker Daniel J. (Director) has filed a Form 4 on Day One Biopharmaceuticals, Inc.
Txns:
| Bought 5,000 shares
@ $16, valued at
$80k
Granted 63,000 options to buy
@ $16, valued at
$1M
|
|
05/26/2021 |
3
| Becker Daniel J. (Director) has filed a Form 3 on Day One Biopharmaceuticals, Inc. |
11/23/2020 |
4
| Becker Daniel J. (Director) has filed a Form 4 on Pandion Therapeutics, Inc.
Txns:
| Bought 197,716 shares
@ $15.12, valued at
$3M
|
|
11/19/2020 |
4
| Becker Daniel J. (Director) has filed a Form 4 on Pandion Therapeutics, Inc.
Txns:
| Bought 2,170 shares
@ $14.63, valued at
$31.7k
Bought 13,027 shares
@ $15.43, valued at
$201k
Bought 14,197 shares
@ $15.26, valued at
$216.6k
|
|
09/28/2020 |
4
| Becker Daniel J. (Director) has filed a Form 4 on Principia Biopharma Inc.
Txns:
| Unknown transaction of 667,600 shares
@ $100, valued at
$66.8M
Disposed/sold 20,475 options to buy
@ $17, valued at
$348.1k
Disposed/sold 10,240 options to buy
@ $31.77, valued at
$325.3k
Disposed/sold 10,240 options to buy
@ $62.66, valued at
$641.6k
|
|
07/21/2020 |
4
| Becker Daniel J. (10% Owner) has filed a Form 4 on Pandion Therapeutics, Inc.
Txns:
| Converted 1,878,551 shares
@ $0 Bought 722,222 shares
@ $18, valued at
$13M
Bought 1,000 shares
@ $18, valued at
$18k
Granted 13,997 options to buy
@ $18, valued at
$251.9k
Converted 9,579,462 preferred shares
@ $0 |
|
07/16/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
06/08/2020 |
4
| Becker Daniel J. (Director) has filed a Form 4 on Principia Biopharma Inc.
Txns:
| Granted 10,240 options to buy
@ $62.66, valued at
$641.6k
|
|
11/22/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
10/30/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
10/22/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/11/2019 |
4
| Becker Daniel J. (Director) has filed a Form 4 on Principia Biopharma Inc.
Txns:
| Granted 10,240 options to buy
@ $31.77, valued at
$325.3k
|
|
01/10/2019 |
4
| Becker Daniel J. (10% Owner) has filed a Form 4 on Principia Biopharma Inc.
Txns:
| Granted 20,475 options to buy
@ $17, valued at
$348.1k
|
|
09/20/2018 |
4
| Becker Daniel J. (10% Owner) has filed a Form 4 on Principia Biopharma Inc.
Txns:
| Converted 1,070,771 shares
@ $0 Converted 312,741 shares
@ $0 Converted 260,617 shares
@ $0 Converted 544,047 shares
@ $0 Converted 167,537 shares
@ $0 Bought 270,000 shares
@ $17, valued at
$4.6M
Converted 1,070,771 convertible preferred
@ $0 Converted 312,741 convertible preferred
@ $0 Converted 260,617 convertible preferred
@ $0 Converted 544,047 convertible preferred
@ $0 Converted 167,537 convertible preferred
@ $0 |
|
09/13/2018 |
3
| Becker Daniel J. (10% Owner) has filed a Form 3 on Principia Biopharma Inc. |
|
|